Design and preparation of biocompatible zwitterionic hydroxyapatite

Sandra Sánchez-Salcedo1, Montserrat Colilla, Isabel Izquierdo-Barba

  • 1Departamento de Química Inorgánica y Bioinorgánica, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain. vallet@ucm.es mcolilla@ucm.es.

Summary

Researchers developed zwitterionic nanocrystalline hydroxyapatite (HA) to prevent bacterial adhesion on implants. This "zwitterionization" process enhances implant safety without compromising biocompatibility, reducing infection risks in clinical applications.

Related Concept Videos